In situ assembly of enzyme inhibitors using extended tethering

被引:159
作者
Erlanson, DA [1 ]
Lam, JW [1 ]
Wiesmann, C [1 ]
Luong, TN [1 ]
Simmons, RL [1 ]
DeLano, WL [1 ]
Choong, IC [1 ]
Burdett, MT [1 ]
Flanagan, WM [1 ]
Lee, D [1 ]
Gordon, EM [1 ]
O'Brien, T [1 ]
机构
[1] Sunesis Pharmaceut Inc, San Francisco, CA 94080 USA
关键词
D O I
10.1038/nbt786
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Cysteine aspartyl protease-3 (caspase-3) is a mediator of apoptosis and a therapeutic target for a wide range of diseases. Using a dynamic combinatorial technology, 'extended tethering', we identified unique nonpeptidic inhibitors for this enzyme. Extended tethering allowed the identification of ligands that bind to discrete regions of caspase-3 and also helped direct the assembly of these ligands into small-molecule inhibitors. We first designed a small-molecule 'extender' that irreversibly alkylates the cysteine residue of caspase-3 and also contains a thiol group. The modified protein was then screened against a library of disulfide-containing small-molecule fragments. Mass-spectrometry was used to identify ligands that bind noncovalently to the protein and that also form a disulfide linkage with the extender. Linking the selected fragments with binding elements from the extenders generates reversible, tight-binding molecules that are druglike and distinct from known inhibitors. One molecule derived from this approach inhibited apoptosis in cells.
引用
收藏
页码:308 / 314
页数:7
相关论文
共 42 条
[1]   α-Haloacetophenone derivatives as photoreversible covalent inhibitors of protein tyrosine phosphatases [J].
Arabaci, G ;
Guo, XC ;
Beebe, KD ;
Coggeshall, KM ;
Pei, D .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1999, 121 (21) :5085-5086
[2]  
ARKIN M, 2003, IN PRESS P NATL ACAD
[3]   Photochemically enhanced binding of small molecules to the tumor necrosis factor receptor-1 inhibits the binding of TNF-α [J].
Carter, PH ;
Scherle, PA ;
Muckelbauer, JA ;
Voss, ME ;
Liu, RQ ;
Thompson, LA ;
Tebben, AJ ;
Solomon, KA ;
Lo, YC ;
Li, Z ;
Strzemienski, P ;
Yang, GJ ;
Falahatpisheh, N ;
Xu, M ;
Wu, ZR ;
Farrow, NA ;
Ramnarayan, K ;
Wang, J ;
Rideout, D ;
Yalamoori, V ;
Domaille, P ;
Underwood, DJ ;
Trzaskos, JM ;
Friedman, SM ;
Newton, RC ;
Decicco, CP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (21) :11879-11884
[4]   Identification of potent and selective small-molecule inhibitors of caspase-3 through the use of extended tethering and structure-based drug design [J].
Choong, IC ;
Lew, W ;
Lee, D ;
Pham, P ;
Burdett, MT ;
Lam, JW ;
Wiesmann, C ;
Luong, TN ;
Fahr, B ;
DeLano, WL ;
McDowell, RS ;
Allen, DA ;
Erlanson, DA ;
Gordon, EM ;
O'Brien, T .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (23) :5005-5022
[5]   P-1 ASPARTATE-BASED PEPTIDE ALPHA-((2,6-DICHLOROBENZOYL)OXY)METHYL KETONES AS POTENT TIME-DEPENDENT INHIBITORS OF INTERLEUKIN-1-BETA-CONVERTING ENZYME [J].
DOLLE, RE ;
HOYER, D ;
PRASAD, CVC ;
SCHMIDT, SJ ;
HELASZEK, CT ;
MILLER, RE ;
ATOR, MA .
JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (05) :563-564
[6]   Site-directed ligand discovery [J].
Erlanson, DA ;
Braisted, AC ;
Raphael, DR ;
Randal, M ;
Stroud, RM ;
Gordon, EM ;
Wells, JA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (17) :9367-9372
[7]   Specific, irreversible inactivation of the epidermal growth factor receptor and erbB2, by a new class of tyrosine kinase inhibitor [J].
Fry, DW ;
Bridges, AJ ;
Denny, WA ;
Doherty, A ;
Greis, KD ;
Hicks, JL ;
Hook, KE ;
Keller, PR ;
Leopold, WR ;
Loo, JA ;
McNamara, DJ ;
Nelson, JM ;
Sherwood, V ;
Smaill, JB ;
Trumpp-Kallmeyer, S ;
Dobrusin, EM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (20) :12022-12027
[8]   Inhibition of human caspases by peptide-based and macromolecular inhibitors [J].
Garcia-Calvo, M ;
Peterson, EP ;
Leiting, B ;
Ruel, R ;
Nicholson, DW ;
Thornberry, NA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (49) :32608-32613
[9]   Involvement of caspases in proteolytic cleavage of Alzheimer's amyloid-β precursor protein and amyloidogenic Aβ peptide formation [J].
Gervais, FG ;
Xu, DG ;
Robertson, GS ;
Vaillancourt, JP ;
Zhu, YX ;
Huang, JQ ;
LeBlanc, A ;
Smith, D ;
Rigby, M ;
Shearman, MS ;
Clarke, FE ;
Zheng, H ;
Van Der Ploeg, LHT ;
Ruffolo, SC ;
Thornberry, NA ;
Xanthoudakis, S ;
Zamboni, RJ ;
Roy, S ;
Nicholson, DW .
CELL, 1999, 97 (03) :395-406
[10]   Selective inactivation of protein tyrosine phosphatase PTP1B by sulfone analogue of naphthoquinone [J].
Ham, SW ;
Park, JG ;
Lee, SJ ;
Yoo, JS .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (02) :185-186